First Allied Advisory Services’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-11,200
Closed -$202K 1140
2016
Q3
$202K Buy
+11,200
New +$202K 0.01% 939